NewsRoom Articles - Page 207 of 222

WednesdaySep 16, 2020 3:30 pm

NIH Ramps Up National Covid-19 Testing Capacity

The National Institutes of Health (“NIH”) recently announced that they had allocated $129.3 million for upscaling and manufacturing new coronavirus testing technology. This would be part of its Rapid Acceleration Diagnostics initiative (RADx). The National Institutes of Health will be awarding the contracts to 9 firms for technologies which include high-throughput labs that can produce results in 24 hours and portable point-of-care tests for immediate results. Francis S. Collins, the NIH director, stated that diagnostic testing was an essential part of the country’s strategy to deal with the coronavirus pandemic. The RADx initiative, which began at the end of April…

WednesdaySep 16, 2020 11:15 am

Options for Individuals with Cancer-Causing Gene Mutations

Genetic testing and counseling services may help in determining if a person has the BRCA1 and BRCA2 gene mutations. Some people may have an inherited mutation in either one or both of these genes that increases their risk of breast cancer. These mutations can be passed to an individual from either of their parents and can affect both men and women. If it turns out that you carry these mutations, then below are some of the options that you have that might help inform you on treatment alternatives as well as cancer prevention. The best person to discuss possible options…

WednesdaySep 16, 2020 11:06 am

Predictive Oncology Inc. (NASDAQ: POAI) Confirms Attendance at Upcoming LD 500 Microcap Investor Conference

Predictive Oncology presenting at upcoming LD 500 investor conference Investor event will take place Sept. 1-4, 2020 and will feature 500 handpicked companies from across North American listed micro-cap universe Predictive Oncology specializes in applying data and artificial intelligence to cancer personalized medicine, drug discovery Predictive Oncology (NASDAQ: POAI), a knowledge-driven medicine company that focuses on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery, has announced that it will be presenting at the upcoming LD 500, an investor conference set to take place in an entirely virtual setting Sept. 1-4, 2020 (http://ibn.fm/42UBB). With 500 handpicked companies…

WednesdaySep 16, 2020 10:30 am

180 Life Sciences Corp. Pursuing Novel Solutions to Inflammatory Illnesses as Merger Nears Completion

180 Life Sciences is a clinical-stage biotechnology company that is developing therapies to combat inflammation in patients with chronic inflammation-related illnesses The company is being acquired by special purpose acquisition corporation KBL Merger Corp. IV (NASDAQ: KBLM) and will be listed on the Nasdaq Capital Market under ticker symbol ATNF when the deal closes later this year Analysts forecast the anti-inflammatory therapeutics market will be worth $191.42 billion by 2027, growing at a CAGR of 3 percent 180 Life Sciences is completing phase 2b/3 clinical trials tackling fibrosis and inflammation-causing TNF substance aberrations The sudden and surprise impact of the…

TuesdaySep 15, 2020 3:15 pm

Penn State Researchers Examine Possibility of Coronavirus Infecting Livestock

The U.S. Department of Agriculture recently awarded a grant to Penn State that will enable its researchers to study the possibility of SARS-CoV-2 infecting and spreading among livestock. SARS-CoV-2 stands for Severe Acute Respiratory Syndrome Coronavirus 2. It is the strain of coronavirus that causes the novel coronavirus which resulted in the global pandemic. The grant, through the USDA’s Agricultural and Food Research Initiative, was awarded to a team that is led by Suresh Kuchipudi, a clinical professor of veterinary and biomedical sciences in the College of Agricultural Sciences. Kuchipudi notes that the coronavirus pandemic is still the most notable…

TuesdaySep 15, 2020 12:15 pm

Researchers Identify Genes Connected to Ovarian Cancer

High grade ovarian carcinoma is a leading cause of cancer-related deaths among women in America, and there is little knowledge concerning the origins of the disease. However, scientists from the College of Veterinary Medicine at Cornell have joined forces on a research study that identifies the exact genes that delay or drive this life-threatening cancer. John Schimenti, a senior author of the study and a professor of genetics from the Department of Biomedical Sciences, stated that he had teamed up with Alexander Nikitin, his colleague who is also a professor of genetics in the same department and the respective members…

MondaySep 14, 2020 2:15 pm

Why Additional Research is Needed to Examine Falls & Aging

Some things are inevitable in life, and you are bound to experience them sooner or later. For instance, aging and falls are some of them. You probably have experienced it or know one or several individuals who have undergone it. Since the world is evolving each day, resources must be directed towards researchers and research, especially in the biomedical field in relation to these realities. Surveys have revealed that almost 10% of the world population consists of people who are 65 years old and above. It has further been predicted that the number is bound to rise by18% by the…

MondaySep 14, 2020 12:00 pm

Uneven Brain Growth Might Be Behind Risky Behavior in Adolescents

Every parent knows that no two children are alike. So you’re wondering why your adolescent children take more risks as compared to the others but you have no explanation? Look no further. Scientists have discovered that in adolescents, the two centers of the brain; the one that makes them want to take risks as well as the other which works on preventing them from acting on these impulses, physically develop at different rates. It is reported that adolescents who have bigger differences in the rates of development of these two centers are much more likely to be risk-takers as compared…

FridaySep 11, 2020 3:30 pm

Maxim Biomedical Plans to Market Millions of COVID-19 Tests This Year

Several biomedical industries are running to look for tests that will rapidly detect individuals infected with COVID-19. One of these biomedical companies is Maxim Biomedical. The company aims at producing millions of Maxim SARS-COV-2 Rapid Antigen Diagnostic Tests for COVID-19. The test is expected to be ready by the end of the year. How the test operates The test will use the Lateral Flow Assay (“LFA”) technology with a sleek workflow and a closed-tube format to avoid the need for a reader or an expensive tool to perform. Its patent, awaiting approval, contains the reagents, specimen swab, and test strip…

FridaySep 11, 2020 12:45 pm

Combining Silk with Synthetic Compounds: The Future of Biomedical Implants

Silk has an extensive history of being used in medical practices. For example, there exist vast records of doctors in the past using fibers that were spun by silkworms to stitch up patients nearly 200 years ago. Today, surgeons sometimes use silk sutures to finish certain operations, like eye surgeries. This is mainly because silk is not only safe for use in a human body but is also tolerated well by the human body. In some instances, the body degrades and absorbs it. This is not silk’s only application. Its potential is limitless as researchers explore the different ways in…